{{Rsnum
|rsid=11615274
|Chromosome=12
|position=73207352
|Orientation=plus
|GMAF=0.1561
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=RP11-314D7.2
|Gene_s=RP11-314D7.2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 55.8 | 38.1 | 6.2
| HCB | 85.4 | 13.1 | 1.5
| JPT | 77.0 | 21.2 | 1.8
| YRI | 91.2 | 8.8 | 0.0
| ASW | 91.2 | 8.8 | 0.0
| CHB | 85.4 | 13.1 | 1.5
| CHD | 81.7 | 16.5 | 1.8
| GIH | 61.4 | 32.7 | 5.9
| LWK | 78.2 | 20.9 | 0.9
| MEX | 82.8 | 17.2 | 0.0
| MKK | 67.3 | 30.8 | 1.9
| TSI | 52.0 | 40.2 | 7.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22417934
|Trait=None
|Title=Genome-wide association study identifies genetic loci associated with body mass index and high density lipoprotein-cholesterol levels during psychopharmacological treatment - a cross-sectional naturalistic study.
|RiskAllele=
|Pval=9E-8
|OR=None
|ORtxt=None
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}